Top

Quality of Life Research

Gepubliceerd in:

18-07-2019 | Brief Communication

A comparison of self-rated health using EQ-5D VAS in the United States in 2002 and 2017

Auteurs: Ashley S. Cha, Ernest H. Law, James W. Shaw, A. Simon Pickard

Gepubliceerd in: Quality of Life Research | Uitgave 11/2019

Abstract

Purpose

To compare self-rated health among the United States general population in 2002 and 2017.

Methods

Secondary data were analyzed from two EQ-5D valuation studies conducted in 2002 and 2017. Both studies included the EQ-5D-3L self-classifier and visual analog scale (VAS), where health is rated from 0 (worst imaginable health) to 100 (best imaginable health). VAS scores were compared between time points using regression models, adjusting for sociodemographic factors (Model 1), plus illness (Model 2), and health problems according to the EQ-5D classifier (Model 3).

Results

Mean VAS scores in 2002 [84.4 (SD = 16.1)] were not different from 2017 [84.6 (SD = 14.5)] (p = 0.63), nor different after adjusting for demographics (Model 1) or illness (Model 2). However, 2017 VAS mean scores were significantly higher than 2002 [2.2 (95% CI 1.36–3.10)] upon adjusting for the presence of dimension-specific health problems.

Conclusions

Self-rated health of the general US adult population in 2017 was similar to 2002, but after adjusting for health problems, scores were slightly higher in 2017. Sociodemographic shifts in age and education explain some of the differences in scores, and by removing health and sociodemographic factors, we found the VAS reveals self-rated health is slightly better in 2017 than 2002.

vorige artikel Disabled life expectancy with and without stroke: a 10-year Japanese prospective cohort study

volgende artikel Development and initial validation of the chronic hepatitis B quality of life instrument (CHBQOL) among Chinese patients

Brazier, J., Ratcliffe, J., Saloman, J., & Tsuchiya, A. (2017). Measuring and valuing health benefits for economic evaluation. Oxford: OXFORD University Press.

Data & Statistics | CDC. Centers for Disease Control and Prevention. Accessed November 10, 2018 from https://www.cdc.gov/nchs/data/hus/hus16.pdf

Feng, Y., Devlin, N., & Herdman, M. (2015). Assessing the health of the general population in England: How do the three- and five-level versions of EQ-5D compare? Health and Quality of Life Outcomes, 13, 171.CrossRef

Pickard, A. S., Hung, Y. T., Lin, F. J., & Lee, T. A. (2017). Patient experience-based value sets: Are they stable? Medical Care, 55(11), 979–984.PubMed

Feeny, D., Kaplan, M. S., Huguet, N., & Mcfarland, B. H. (2010). Comparing population health in the United States and Canada. Population Health Metrics, 8, 8.CrossRef

Parrish, R. G. (2010). Measuring population health outcomes. Preventing Chronic Disease, 7(4), A71.PubMedPubMedCentral

Pickard, A. S. (2015). Is it time to update societal value sets for preference-based measures of health? Pharmacoeconomics, 33(3), 191–192.CrossRef

National Center for Health Statistics. Centers for Disease Control and Prevention. Published April 9, 2018. Accessed November 10, 2018 from https://www.cdc.gov/nchs/hus/contents2016.htm

Feng, Y., Herdman, M., Van nooten, F., et al. (2017). An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D. Quality of Life Research, 26(8), 2067–2078.CrossRef

10.

Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43(3), 203–220.CrossRef

11.

Law, E. H., Pickard, A. S., Xie, F., Walton, S. M., Lee, T. A., & Schwartz, A. (2018). Parallel valuation: A direct comparison of EQ-5D-3L and EQ-5D-5L societal value sets. Medical Decision Making, 38(8), 968–982.CrossRef

12.

Pickard, A. S., Law, E. H., Jiang, R., Oppe, M., Shaw, J. W., Xie, F., et al. (2018). United States valuation of EQ-5D-5L health states: An initial model using a standardized protocol. Value in Health, 21, S4–S5.CrossRef

13.

Wisløff, T., Hagen, G., Hamidi, V., Movik, E., Klemp, M., & Olsen, J. A. (2014). Estimating QALY gains in applied studies: A review of cost-utility analyses published in 2010. Pharmacoeconomics, 32(4), 367–375.CrossRef

14.

Rabin, R., Oemar, M., Oppe, M., Janssen, B., & Herdman, M. (2011). EQ-5D-3L user guide. Basic information on how to use the EQ-5D-5L instrument. EuroQol Group: Rotterdam.

15.

Pullenayegum, E. M., Tarride, J.-E., Xie, F., Goeree, R., Gerstein, H. C., & O’reilly, D. (2010). Analysis of health utility data when some subjects attain the upper bound of 1: Are Tobit and CLAD models appropriate? Value in Health, 13(4), 487–494.CrossRef

16.

Huber, M., Vogelmann, M., & Leidl, R. (2018). Valuing health-related quality of life: Systematic variation in health perception. Health and Quality of Life Outcomes, 16(1), 156.CrossRef

17.

Murray, C. J. L., & Lopez, A. D. (2017). Measuring global health: Motivation and evolution of the global burden of disease study. Lancet, 390(10100), 1460–1464.CrossRef

18.

Blumenthal, D., Abrams, M., & Nuzum, R. (2015). The affordable care act at 5 years. New England Journal of Medicine, 373(16), 1580.CrossRef

19.

The State of American Jobs. Pew Research Center’s Social & Demographic Trends Project. Published October 9, 2017. Accessed November 10, 2018 from http://www.pewsocialtrends.org/2016/10/06/the-state-of-american-jobs/

20.

Liu J. Views on End-of-Life Medical Treatments. Pew Research Center’s Religion & Public Life Project. Published October 31, 2014. Accessed November 20, 2018 from http://www.pewforum.org/2013/11/21/views-on-end-of-life-medical-treatments/

Titel: A comparison of self-rated health using EQ-5D VAS in the United States in 2002 and 2017
Auteurs: Ashley S. Cha
Ernest H. Law
James W. Shaw
A. Simon Pickard
Publicatiedatum: 18-07-2019
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 11/2019
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-019-02249-y

Andere artikelen Uitgave 11/2019

Prevalence of anxiety in patients with an implantable cardioverter defibrillator: measurement equivalence of the HADS-A and the STAI-S

Open Access

Cancer survivor perspectives on sharing patient-generated health data with central cancer registries

Impact of comorbidities and functional impairment on 5-year loss of health utility in patients with lower-limb osteoarthritis in the KHOALA cohort

Disabled life expectancy with and without stroke: a 10-year Japanese prospective cohort study

The moderating role of age in the relationship between different stressors and the quality of life of the relatives of people with intellectual disabilities

Correspondence of directly reported and recalled health-related quality of life in a large heterogeneous sample of trauma patients

Open Access